Business Description
Biocure Technology Inc
NAICS : 325412
SIC : 3741
ISIN : CA09075T1075
Compare
Compare
Traded in other countries / regions
CURE.Canada1WH.GermanyBICTF.USA IPO Date
2010-05-10Description
Biocure Technology Inc is a South Korean-based Bio-Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is in the process of preclinical trials of five majorly biosimilar products in South Korea, including Interferon Beta 1b, PEGFilgrastim, and Ranibizumab as well as CAR-T Cell Therapy. Interferon Beta 1b is used for treating relapsing forms of multiple sclerosis Filgrastim is used to treat neutropenia, a lack of certain white blood cells caused by bone marrow transplants, chemotherapy, and other conditions. Ranibizumab is used for treating macular degeneration. It is also used to treat a type of eye problem known as macular edema, as well as certain eye problems caused by diabetes.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 17 | |||||
| 3-Year EPS without NRI Growth Rate | 18.1 | |||||
| 3-Year FCF Growth Rate | 46.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -66.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.03 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 2 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -338.88 | |||||
| ROA % | -68.67 | |||||
| ROIC % | -28.44 | |||||
| ROCE % | -313.98 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.58 | |||||
| PE Ratio without NRI | 0.83 | |||||
| PEG Ratio | 0.02 | |||||
| PB Ratio | 0.88 | |||||
| Price-to-Tangible-Book | 0.88 | |||||
| EV-to-EBIT | 0.62 | |||||
| EV-to-EBITDA | 0.62 | |||||
| EV-to-FCF | -6.87 | |||||
| Earnings Yield (Greenblatt) % | 161.29 | |||||
| FCF Yield % | -31.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biocure Technology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | 0.026 | ||
| Beta | 4.87 | ||
| Volatility % | 73.65 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (C$) | 0.000007 | ||
| 20-Day SMA (C$) | 0.015 | ||
| 12-1 Month Momentum % | -66.67 | ||
| 52-Week Range (C$) | 0.015 - 0.045 | ||
| Shares Outstanding (Mil) | 94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biocure Technology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biocure Technology Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biocure Technology Inc Frequently Asked Questions
What is Biocure Technology Inc(XCNQ:CURE)'s stock price today?
The current price of XCNQ:CURE is C$0.02. The 52 week high of XCNQ:CURE is C$0.05 and 52 week low is C$0.02.
When is next earnings date of Biocure Technology Inc(XCNQ:CURE)?
The next earnings date of Biocure Technology Inc(XCNQ:CURE) is .
Does Biocure Technology Inc(XCNQ:CURE) pay dividends? If so, how much?
Biocure Technology Inc(XCNQ:CURE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers